- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04632602
Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure (ProneSpontCov)
Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure: a Randomized Cross Over Electrical Impedance Tomography Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Marseille, France, 13354
- Assistance Publique Hopitaux de Marseille
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- more than 18 Years (Adult, Older Adult)
- Confirmed COVID-19 (positive SARS-CoV-2 RT-PCR at nasopharyngeal swab)
- Acute respiratory failure with 100 < PaO2:FiO2< 300 mmhg
- Spontaneous ventilation with standard oxygen supply or high flow humidified oxygen
- Written informed consent of the patient
Exclusion Criteria:
- Contra-indication to prone position including pregnancy
- Presence of pacemaker
- Severe hypoxemia with PaO2/FiO2 < 100 mmHg
- Evidence of clinical signs of respiratory distress with high probability of intubation in the next two hours
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: patients in prone position followed by dorsal decubitus
patients will be randomized on the order of position, either supine then prone, either prone then supine.
Each period will last at least 2 hours.
|
Study of physiological effects of awake prone position in COVID 19 patients on lung inhomogeneity assessed by Electrical Impedance Tomography (EIT), gas exchange and dyspnea score (Borg Scale). Measurements will be performed at baseline (on supine position), then patients will be randomized on the order of position, either supine then prone, either prone then supine. Each period will last at least 2 hours. EIT records will be performed during the last 30 minutes of each period, blood gas and dyspnea score at the end of each period. |
|
Other: dorsal decubitus followed by prone decubitus
patients will be randomized on the order of position, either supine then prone, either prone then supine.
Each period will last at least 2 hours.
|
Study of physiological effects of awake prone position in COVID 19 patients on lung inhomogeneity assessed by Electrical Impedance Tomography (EIT), gas exchange and dyspnea score (Borg Scale). Measurements will be performed at baseline (on supine position), then patients will be randomized on the order of position, either supine then prone, either prone then supine. Each period will last at least 2 hours. EIT records will be performed during the last 30 minutes of each period, blood gas and dyspnea score at the end of each period. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Global Inhomogeneity Index variations (expressed in percentage) between baseline, supine and prone position periods.
Time Frame: 2hours
|
Electrical Impedance Tomography (EIT)
|
2hours
|
Collaborators and Investigators
Investigators
- Study Director: jean-olivier ARNAUD, Assistance Publique Hopitaux de Marseille
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-17
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Failure
-
University Hospital, Strasbourg, FranceRecruitingRespiratory Failure | Cardiac FailureFrance
-
Hemovent GmbHseleon GmbHRecruitingRespiratory Failure | Cardiac Failure | Cardio-Respiratory Failure | Imminent Cardiorespiratory or Respiratory FailureGermany
-
Catholic University of the Sacred HeartFisher and Paykel HealthcareCompletedWeaning Failure | Acute Respiratory FailureFrance, Greece, Italy, Spain
-
Efficacy Care R&D LtdMemorial Hermann Hospital; CRG Medical, Inc.UnknownShock | Shock, Septic | Respiratory Failure | Respiratory Distress Syndrome | Shock, Cardiogenic | Acute Cardiac Failure | Acute Respiratory Failure | Acute Kidney Failure | Multi Organ Failure | Respiratory Arrest | Acute Respiratory Failure With Hypoxia | Acute Respiratory Failure Requiring Reintubation | Acute... and other conditionsUnited States
-
UPECLIN HC FM Botucatu UnespUnknownExtubation Failure | Acute Respiratory Failure Post ExtubationBrazil
-
Hospital Clinic of BarcelonaCompletedHypercapnic Respiratory Failure | Hypoxemic Respiratory FailureSpain
-
University of OsloOslo University HospitalCompletedHypercapnic Respiratory Failure | Type 2 Respiratory FailureNorway
-
Fisher and Paykel HealthcareCentre hospitalier de l'Université de Montréal (CHUM); Institut universitaire...RecruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory FailureCanada
-
Siriraj HospitalCompletedAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory FailureThailand
-
University Hospital, AngersNot yet recruitingCardio-Respiratory FailureFrance
Clinical Trials on physiological effects of awake prone position in COVID 19 patients
-
Saglik Bilimleri Universitesi Gulhane Tip FakultesiCompletedNursing Caries | PretermTurkey
-
University Hospital, GhentUniversitaire Ziekenhuizen KU Leuven; Jessa Hospital; University Hospital, Antwerp and other collaboratorsCompletedCritical Illness | Acute Kidney Injury | COVID-19 PneumoniaBelgium
-
National Institute of Medical Sciences and Nutrition...Completed
-
University of JordanCompletedAnesthesia | Anorectal SurgeryJordan
-
Hospital Moinhos de VentoPfizer; Universidade Federal do Paraná; Inova MedicalCompleted
-
Ain Shams UniversityUnknownCoronavirus Disease (COVID-19)Egypt
-
Huntington Memorial HospitalCompletedCovid19 | Vaccine ReactionUnited States
-
WestVac Biopharma Co., Ltd.WithdrawnCOVID-19 | SARS-CoV-2 InfectionMexico
-
Yisheng Biopharma (Singapore) Pte. Ltd.CompletedCovid-19 VaccineUnited Arab Emirates, Philippines
-
The First Affiliated Hospital of Soochow UniversityWithdrawnHematologic DiseasesChina